当前位置:首页 - 行情中心 - 普洛药业(000739) - 财务分析 - 现金流量表

普洛药业

(000739)

  

流通市值:277.92亿  总市值:278.03亿
流通股本:11.58亿   总股本:11.58亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,336,128,726.071,737,971,817.287,904,152,454.145,798,660,551.63
  收到的税费返还142,083,454.3699,466,050.03369,467,740.48304,318,738.35
  收到其他与经营活动有关的现金94,323,238.6538,124,665.53270,785,586.97190,903,061.33
  经营活动现金流入小计3,572,535,419.081,875,562,532.848,544,405,781.596,293,882,351.31
  购买商品、接受劳务支付的现金2,240,334,034.161,028,481,894.45,147,723,410.543,824,738,181.96
  支付给职工以及为职工支付的现金572,284,698.26350,619,906.11986,577,353.54710,162,856.09
  支付的各项税费355,903,155.01215,422,531.49481,977,236.19402,637,442.7
  支付其他与经营活动有关的现金329,684,032.25156,065,558.57707,926,500.57582,319,763.89
  经营活动现金流出小计3,498,205,919.681,750,589,890.577,324,204,500.845,519,858,244.64
  经营活动产生的现金流量净额74,329,499.4124,972,642.271,220,201,280.75774,024,106.67
二、投资活动产生的现金流量:
  收回投资收到的现金1,028,843,418.761,057,022,526.721,238,929,600.55943,187,974.61
  取得投资收益收到的现金--10,468,676.8910,468,676.89
  处置固定资产、无形资产和其他长期资产收回的现金净额460,000-33,027,522.952,354,172.45
  处置子公司及其他营业单位收到的现金净额--30,177,588.0230,054,923.33
  收到的其他与投资活动有关的现金883,444.5-266,572.74265,160.64
  投资活动现金流入小计1,030,186,863.261,057,022,526.721,312,869,961.15986,330,907.92
  购建固定资产、无形资产和其他长期资产支付的现金229,053,008.05109,428,231.2386,214,539.82219,483,024.29
  投资支付的现金1,047,225,548.561,062,111,4001,298,545,5001,004,745,500
  支付其他与投资活动有关的现金705,816.8-427,910.98427,910.98
  投资活动现金流出小计1,276,984,373.411,171,539,631.21,685,187,950.81,224,656,435.27
  投资活动产生的现金流量净额-246,797,510.15-114,517,104.48-372,317,989.65-238,325,527.35
三、筹资活动产生的现金流量:
  取得借款收到的现金720,000,000240,000,0002,134,900,0001,620,900,000
  收到其他与筹资活动有关的现金28,068,700---
  筹资活动现金流入小计748,068,700240,000,0002,134,900,0001,620,900,000
  偿还债务支付的现金712,000,000188,000,0001,416,000,0001,164,000,000
  分配股利、利润或偿付利息支付的现金285,944,475.038,957,136.08836,106,817.82836,012,075.14
  支付其他与筹资活动有关的现金67,659,879.9729,336,574.67525,879,626.33190,673,547.93
  筹资活动现金流出小计1,065,604,355226,293,710.752,777,986,444.152,190,685,623.07
  筹资活动产生的现金流量净额-317,535,65513,706,289.25-643,086,444.15-569,785,623.07
四、汇率变动对现金及现金等价物的影响-30,480,895.92-16,375,254.92-9,951,342.783,355,523.37
五、现金及现金等价物净增加额-520,484,561.677,786,572.12194,845,504.17-30,731,520.38
  加:期初现金及现金等价物余额2,924,290,064.232,924,290,064.232,729,444,560.062,729,444,560.06
  期末现金及现金等价物余额2,403,805,502.562,932,076,636.352,924,290,064.232,698,713,039.68
补充资料:
  净利润522,563,447.12-890,681,701.93-
  资产减值准备48,488,025.78-83,431,190.26-
  固定资产和投资性房地产折旧328,411,779.97-652,302,409.38-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧328,411,779.97-652,302,409.38-
  无形资产摊销5,312,395.04-10,082,544.47-
  长期待摊费用摊销5,234,153.2-9,085,712.96-
  处置固定资产、无形资产和其他长期资产的损失-136,291.96--9,032,000.65-
  固定资产报废损失392,722.78-1,686,363.84-
  公允价值变动损失-7,637,055.28---
  财务费用40,325,181.4-34,354,081.4-
  投资损失-7,890,026.96--30,194,921.98-
  递延所得税618,602.12--24,321,718.92-
  其中:递延所得税资产减少6,993,290.74--7,038,549.9-
    递延所得税负债增加-6,374,688.62--17,283,169.02-
  存货的减少-27,012,695.1-165,584,111.48-
  经营性应收项目的减少-624,023,805.59--227,868,060.56-
  经营性应付项目的增加-214,033,555.36--342,738,844.61-
  其他--525,492.83-
  现金的期末余额2,403,805,502.56-2,924,290,064.23-
  减:现金的期初余额2,924,290,064.23-2,729,444,560.06-
  现金及现金等价物的净增加额-520,484,561.67-194,845,504.17-
公告日期2026-08-202026-04-212026-03-202025-10-22
审计意见(境内)标准无保留意见
TOP↑